bilaterals.org logo
bilaterals.org logo

medicines


Editorial: New Zealand must tread carefully on Trans Pacific Partnership
New Zealand needs to be ready to walk away from the Trans Pacific Partnership, says The Domion Post, worried about the impact of its drug patenting rules and investor-state dispute settlement mechanism.
Leaked: What’s in Obama’s trade deal
A recent draft of the Trans-Pacific Partnership free-trade deal would give US pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in US law.
AFTINET: Reply to the Department of Foreign Affairs and Trade Myths and Realities document, June 2015
The Australian government misrepresents the claims of critics and fails to address substantial criticisms of the Trans Pacific Partnership, says civil society network AFTINET.
Pressure intensifies on India over software and pharma patent protection in key Asian trade negotiations
Recently leaked documents show that India’s policies on software and pharmaceutical patents are firmly on the RCEP agenda.
Trade deal widens health care gap
NZ is heading towards a two-tier health system, and it could get a whole lot worse, writes George Laking.
Civil Society raises major concerns on India’s engagement with the massive RCEP trade deal
As the eighth round of negotiations on the Regional Comprehensive Economic Partnership (RCEP) trade agreement take place in Kyoto, Japan this week, farmer’s groups, trade unions, civil society and patient groups are urging the Indian Government to halt the negotiations, make the negotiating texts public and hold consultations with all the relevant stakeholders, in light of the potential negative impact this agreement could have on access to medicines, livelihood of farmers, quality public services and overall social and economic development of the country.
WikiLeaks publishes healthcare annex to "transparency" chapter of TPP
On Wednesday 10 June 2015, WikiLeaks published the Healthcare Annex to the secret draft "Transparency" Chapter of the Trans-Pacific Partnership Agreement (TPP), along with each country’s negotiating position.
What does the TPP do as regards prices of drugs and other medical technologies?
Two-page summary of the main provisions in the Trans-Pacific Partnership Agreement (TPP) that will lead to higher prices for drugs and other medical technologies.
Intellectual property issues viewed as last TPP hurdle
Trade negotiators for the Trans-Pacific Partnership agreement in Guam are now focusing on intellectual property issues, which appear likely to be the last hurdle to concluding the talks.
TPP denounced in Peru as US-led negotiations end
On Monday, a coalition of Peruvian civil society organizations issued a strong warning as negotiations for the Trans Pacific Partnership treaty (TPP) come to an end.
A major AIDS research groups says the TPP will make it harder to fight AIDS
A new report from the prominent AIDS research group amfAR says that the Trans-Pacific Partnership would hamper the global fight against AIDS (and other diseases) in a way that would ultimately cost lives.
The Transpacific Partnership will impact sovereign control over health policies
A text that Peru and 11 other countries (including the US) are negotiating in secret, seeks to expand drug patents for more than 20 years thus generating millions of overheads for our health system and making it even more difficult to obtain biological medicines against cancer.
Trans-Pacific Partnership: Trade deal could force Australian Government to spend millions to subsidise medicines, expert warns
Australia’s primary negotiator on medicines for the US-Australia FTA, Dr Ruth Lopert, warns that the TPP could force the Australian Government to spend hundreds of millions of dollars to subsidise medicines.
Intellectual property issues hinder TPP talks in Hawaii
Chief negotiators in Trans-Pacific Partnership talks failed to iron out differences over the last week, with intellectual property protection on medicines and environmental protection being key stumbling blocks.
US Ambassador confirms patent linkage under FTA includes biologics
The US Ambassador Lippert has sent a letter to the Korean Minister of Food and Drug Safety requesting protection of biologics under the patent linkage system. He also confirmed that the US seeks the same protection in TPP.
TPP free trade agreement would increase cost of medicine In Mexico, Peru, Chile, and other countries
TPP — the Trans-PacificPartnership — is making waves from Peru to Australia, concerning public health officials and consumer advocates.
Will a new US-led IP empire in India put access to medicines at risk?
Prof Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with the US and its investors is dangerous to hundreds of millions of people worldwide whose lives depend on Indian generics
Affordable medicines could be at risk as US seeks to firm up protections
Access to affordable medicines could be under threat in Australia if the United States gets its way in secretive negotiations over a massive trade deal involving 12 Pacific-region countries, academics have warned.
DNP+ response to RCEP negotiations on Intellectual Property ongoing in Thailand
Japan is pushing for intellectual property rules in the Regional Comprehensive Economic Partnership that will undermine and delay access to affordable generic medecine in Asia.
Calling TPP a ’death pact,’ health advocates rally outside secretive trade talks
Braving snow and blizzard warnings, health, labor and environmental activists rallied outside a New York City hotel on Monday where industry leaders met with international trade representatives to commence the "final negotiations" over the secret text of the Trans-Pacific Partnership.